The new drug activates special antibodies, which subsequently block the development of infection.
Scientists from the Duke Institute in the United States have created a new vaccine against all dangerous types of coronavirus infection. The drug has already been tested in preclinical trials.
It is noted that the vaccine, using nanoparticles, activates antibodies consisting of fragments of coronavirus and adjuvan.
- Brief Anger Hampers Blood Vessel Function Leading to Increased Risk of Heart Disease and Stroke – New Study
- New Blood Test Pinpoints Future Stroke Risk – Study Identifies Inflammatory Molecules as Key Biomarker
- Enceladus: A Potential Haven for Extraterrestrial Life in its Hidden Ocean Depths
- New Experiment: Dark Matter Is Not As ‘DARK’ As All We Think
- Scientists in Fear of This New Predator From Red Sea Eating Native Species in Mediterranean
The latter is a special binding agent that enhances the immune response to the ingress of an immunogen into the human body.
Tests on macaques and mice have shown that in this way, different strains of coronavirus infection, including SARS-CoV-2, can be successfully neutralized by 100%.
Researchers claim that the new vaccine is many times more effective at neutralizing the infection than currently used.
The results of the study, yet to be peer reviewed, are published in the scientific journal Nature.
Image Credit: iStock
